Quadrant Capital Group LLC Royalty Pharma PLC Transaction History

Quadrant Capital Group LLC

$1.42 Billion
Q3 2024

A detailed history of Quadrant Capital Group LLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Quadrant Capital Group LLC holds 1,160 shares of RPRX stock, worth $28,164. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,160

Previous 1,778 34.76%

Holding current value

$28,164

Previous $46,000 30.43%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$25.63 - $29.27 $15,839 - $18,088	-618 Reduced 34.76%	1,160 $32,000
Q2 2024 Aug 12, 2024	SELL	$26.26 - $29.9 $58,034 - $66,079	-2,210 Reduced 55.42%	1,778 $46,000
Q1 2024 May 15, 2024	BUY	$27.46 - $31.33 $13,757 - $15,696	501 Added 14.37%	3,988 $121,000
Q4 2023 Feb 08, 2024	BUY	$26.21 - $29.22 $68,303 - $76,147	2,606 Added 295.8%	3,487 $97,000
Q3 2023 Nov 14, 2023	BUY	$26.26 - $31.38 $17,121 - $20,459	652 Added 284.72%	881 $23,000
Q2 2023 Aug 09, 2023	SELL	$29.6 - $36.56 $8,584 - $10,602	-290 Reduced 55.88%	229 $7,000
Q1 2023 May 11, 2023	BUY	$32.77 - $39.4 $9,273 - $11,150	283 Added 119.92%	519 $18,000
Q4 2022 Feb 10, 2023	SELL	$39.17 - $44.04 $509 - $572	-13 Reduced 5.22%	236 $9,000
Q3 2022 Nov 10, 2022	SELL	$39.88 - $44.65 $4,705 - $5,268	-118 Reduced 32.15%	249 $10,000
Q2 2022 Aug 09, 2022	SELL	$37.53 - $44.22 $262 - $309	-7 Reduced 1.87%	367 $15,000
Q1 2022 May 06, 2022	BUY	$37.46 - $42.44 $4,570 - $5,177	122 Added 48.41%	374 $14,000
Q4 2021 Feb 01, 2022	BUY	$35.17 - $42.48 $7,104 - $8,580	202 Added 404.0%	252 $10,000
Q3 2021 Nov 12, 2021	SELL	$36.14 - $42.24 $7,842 - $9,166	-217 Reduced 81.27%	50 $2,000
Q2 2021 Aug 09, 2021	BUY	$39.85 - $46.63 $10,520 - $12,310	264 Added 8800.0%	267 $11,000
Q4 2020 Feb 16, 2021	BUY	$36.12 - $50.05 $108 - $150	3 New	3 $0

Others Institutions Holding RPRX

# of Institutions

413

Shares Held

283M

Call Options Held

578K

Put Options Held

47.5K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $10.6B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.

Account

Quadrant Capital Group LLC Royalty Pharma PLC Transaction History